Total hip arthroplasty using bone cement containing tri-n-butylborane as the initiator

We performed total hip arthroplasty (THA) using a special acrylic self-curing bone cement (Bonemite), which contains tri-n-butylborane as the initiator. Its maximum temperature at curing is lower than that of a conventional bone cement (CMW). Fifty-eight THAs using Bonemite and 35 THAs using CMW were followed up for more than 8 years (12.5 years on average). At the 10-year follow-up, the survival rates, using revision surgery or aseptic loosening impending revision as the endpoint for failure, were 92.2% for the patients in the Bonemite group and 91.0% for those in the CMW group. No statistical differences were observed between the patients in these two groups with regard to survival rate (p = 0.39). Bonemite showed no clear superiority compared with CMW, although the results suggest that Bonemite is safe and reliable for clinical use and stable in situ for long time.